[Comparative characteristics of the hypoglycemic effect of a new 3,5-dioxopyrazolidine derivative, DSB, and butamide].
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology*; D011817:Rabbits; D013449:Sulfonamides / Q000494:pharmacology*; D014044:Tolbutamide / Q000494:pharmacology*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D011720:Pyrazoles; D013449:Sulfonamides; D014044:Tolbutamide
Sravnitel'naia kharakteristika gipoglikemiziruiushchego éffekta novogo proizvodnogo 3,5-dioksopirazolidina DSB i butamida